» Articles » PMID: 18660717

Central Neuronal Mechanisms in Cancer-induced Bone Pain

Overview
Date 2008 Jul 29
PMID 18660717
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: To consider distinct neuropharmacological substrates that underlie transmission of impulses from the periphery to the central nervous system in cancer pain.

Recent Findings: Advances reveal that plasticity, the ability of the nervous system to alter in response to external events, leads to changes throughout the pathways involved in the perception of pain. Exploitation of pharmacological, functional, molecular and genomic techniques is a basis for new insights into the molecular and cellular mechanisms that contribute to the pain that follows pathophysiology. Characteristic changes experienced with chronic or persistent pain from various causes include expanded receptive fields, allodynia and spontaneous pain in the absence of external stimuli. In addition there are the affective and emotional responses that have to be considered along with these sensory aspects of pain.

Summary: It is clear that although the sensory and psychological aspects of pain are separable, the neural pathways that contribute to these aspects of pain are interlinked. Furthermore, at both peripheral and central sites, there are mechanisms that amplify and prolong the painful stimulus--this can result in severe pain in the presence of relatively minor peripheral pathology. This review considers these signalling systems and changes therein in the context of pain in cancer.

Citing Articles

Hematology patients' metaphorical perceptions of the disease and psychosocial support needs in the treatment process: a phenomenological study from a rural region of Türkiye.

Uzun S, Ediz C, Mohammadnezhad M Support Care Cancer. 2025; 33(3):222.

PMID: 40000464 PMC: 11860990. DOI: 10.1007/s00520-025-09278-z.


AIM2 promotes excitatory glutamate receptor expression by inhibiting STING and contributes to bone cancer pain in male mice.

Wang L, Xu X, Su S, Li B, Zhang K, Yu X Sci Rep. 2024; 14(1):31851.

PMID: 39738518 PMC: 11685590. DOI: 10.1038/s41598-024-83027-w.


Meta-analysis of the effect of sophora flavescens on tumor metastasis-induced bone neuropathic pain.

Chang C, Sun D, Zhang Z, He L, Wang Q, Shen Y Front Pharmacol. 2024; 15:1474982.

PMID: 39629083 PMC: 11611551. DOI: 10.3389/fphar.2024.1474982.


A Rare Skeletal Disorder, Fibrous Dysplasia: A Review of Its Pathogenesis and Therapeutic Prospects.

Kim H, Shim J, Heo C Int J Mol Sci. 2023; 24(21).

PMID: 37958575 PMC: 10650015. DOI: 10.3390/ijms242115591.


The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.

Appel C, Gallego-Pedersen S, Andersen L, Blancheflor Kristensen S, Ding M, Falk S Sci Rep. 2017; 7(1):4792.

PMID: 28684771 PMC: 5500481. DOI: 10.1038/s41598-017-05029-1.